Sanofi (LON:0A2V)

London flag London · Delayed Price · Currency is GBP · Price in USD
46.43
+1.21 (2.67%)
At close: Aug 1, 2025
2.67%
Market Cap85.31B
Revenue (ttm)39.21B
Net Income (ttm)7.82B
Shares Outn/a
EPS (ttm)6.30
PE Ratio10.91
Forward PE9.83
Dividend1.20 (2.59%)
Ex-Dividend DateMay 9, 2025
Volume1,625
Average Volume71,481
Open44.46
Previous Close45.22
Day's Range44.39 - 46.59
52-Week Range44.75 - 60.08
Betan/a
RSI30.51
Earnings DateJul 31, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 82,878
Stock Exchange London Stock Exchange
Ticker Symbol 0A2V
Full Company Profile

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.